-

01:59:16 AM

XXII Stock News

XXII - 22nd Century Group Inc

01/24/23 9:20 AM

Nasdaq : XXII

acquisition

22nd Century Group (XXII) Acquires RX Pharmatech Ltd, Greatly Strengthening UK and EU Market Position

22nd Century Group, Inc. (Nasdaq: XXII ),

RHEA-AI

very positive

01/23/23 9:20 AM

Nasdaq : XXII

22nd Century Group (XXII) Announces Filing of U.S. DMF (Drug Master File) for CBD API; New Global Sales, Marketing and Distribution Agreement with Transo-Pharm for Cannabinoid APIs

22nd Century Group, Inc. (Nasdaq: XXII ), a leading biotechnology company dedicated to improving

RHEA-AI

very positive

11/16/22 9:25 AM

Nasdaq : XXII

22nd Century Group’s GVB Biopharma Opens New Central Distribution Facility in The Netherlands

GVB Biopharma , a 22nd Century Group company (Nasdaq: XXII ), today announced that it has opened a new, strategically-located distribution facility in the

RHEA-AI

neutral

11/15/22 9:25 AM

Nasdaq : XXII

22nd Century Group (Nasdaq: XXII) GVB Biopharma to Exhibit at MJBizCon in Las Vegas

22nd Century Group, Inc. (Nasdaq: XXII ), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, today announced that the Company’s GVB

RHEA-AI

neutral

11/14/22 8:19 AM

Nasdaq : XXII

conferences

22nd Century Group (Nasdaq: XXII) to Participate in November 2022 Investor Conferences

22nd Century Group, Inc. (Nasdaq: XXII ), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, today announced that the Company will be

RHEA-AI

neutral

11/08/22 6:00 AM

Nasdaq : XXII

earnings

22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the Third Quarter 2022

Accelerating VLN ® Sales in Colorado and Illinois, Launching in Four Corners States to Capture Market Share and Volume GVB Biopharma Acquisition Growing Revenue on Increased Volumes Third Quarter Net Sales $19.4 Million, Up 148% from the Third Quarter 2021 Strong Balance Sheet to Support Strategic

RHEA-AI

neutral

11/07/22 9:43 AM

Nasdaq : XXII

New Study Again Shows 22nd Century’s Reduced Nicotine Content Cigarettes Reduce Cigarette Consumption and Increase Smoking Cessation

RHEA-AI

neutral

10/27/22 9:15 AM

Nasdaq : XXII

22nd Century Group (Nasdaq: XXII) to Announce Third Quarter 2022 Results on November 8, 2022

22nd Century Group, Inc. (Nasdaq: XXII ), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, will release third quarter 2022 financial

RHEA-AI

neutral

10/26/22 9:25 AM

Nasdaq : XXII

22nd Century Group (Nasdaq: XXII) to Expand VLN® Sales in Three Additional States: Arizona, Utah and New Mexico

22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural

RHEA-AI

positive

10/18/22 9:20 AM

Nasdaq : XXII

conferences

22nd Century Group (Nasdaq: XXII) to Present at LD Micro Conference on October 26

22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, today announced that James A. Mish, chief

RHEA-AI

neutral

1 2 3 4 5 6 7 8 9 10 Next